Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:38
Elutia Profit Margin (Quarterly) : -571.9% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -571.9% |
| June 30, 2026 | -315.0% |
| March 31, 2026 | -253.5% |
| December 31, 2025 | -199.0% |
| September 30, 2025 | -110.6% |
| June 30, 2025 | -258.1% |
| March 31, 2025 | -63.94% |
| December 31, 2024 | -254.1% |
| September 30, 2024 | 85.20% |
| June 30, 2024 | -450.8% |
| March 31, 2024 | -268.8% |
| December 31, 2023 | -259.1% |
| September 30, 2023 | -139.0% |
| June 30, 2023 | -121.7% |
| Date | Value |
|---|---|
| March 31, 2023 | -153.0% |
| December 31, 2022 | -91.25% |
| September 30, 2022 | -188.6% |
| June 30, 2022 | -74.36% |
| March 31, 2022 | -70.89% |
| December 31, 2021 | -83.45% |
| September 30, 2021 | -72.41% |
| June 30, 2021 | -19.61% |
| March 31, 2021 | -39.33% |
| December 31, 2020 | -42.96% |
| September 30, 2020 | -57.17% |
| June 30, 2020 | -60.36% |
| March 31, 2020 | -46.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 4.98% |
| Amgen, Inc. | 37.29% |
| Anika Therapeutics, Inc. | -1.02% |
| BioCryst Pharmaceuticals, Inc. | 21.03% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -382.2% |
| Return on Assets | -59.78% |
| Return on Invested Capital | -113.8% |
| Gross Profit Margin (Quarterly) | 61.74% |
| Operating Margin (Quarterly) | -596.2% |
| Return on Net Operating Assets | -269.4% |